TLR4 and infection: The secreted nature of EhaF prompted us to test if EhaF-containing supernatant fraction itself is sufficient to suppress proinflammatory responses by pretreating BMDMs with supernatant from BL21/pEhaF-FLAG or BL21/pEmpty prior to infection or treatment with TLR4 stimuli.